540788
ASPIRA
Start SIP
Invest Now
Start SIP in ASPIRA
Aspira Pathlab & Diagnostics live price: ₹60.16. It opened at ₹61 vs previous close ₹55; intraday high/low: ₹61/₹55. The 50 & 200 DMA stand at ₹61.30/₹62.31.
Aspira Pathlab & Diagnostics Performance
- Low
- ₹55
- High
- ₹61
- 52 Week Low
- ₹50
- 52 Week High
- ₹107
- Open Price₹61
- Previous Close₹55
- Volume70
- 50 DMA₹61.30
- 100 DMA₹62.43
- 200 DMA₹62.31
Investment Returns
- Over 1 Month -0.64%
- Over 3 Month -12.39%
- Over 6 Month -2.95%
- Over 1 Year -28.44%
Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!
Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 42.2
- PEG Ratio
- 0.6
- Market Cap Cr
- 62
- P/B Ratio
- 4.8
- Average True Range
- 5.34
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.48
- RSI
- 50.55
- MFI
- 54.51
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Technicals
EMA & SMA
Current Price
₹60.16
+
5.16
(9.38%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹59.19
- 50 Day
- ₹61.30
- 100 Day
- ₹62.43
- 200 Day
- ₹62.31
Resistance and Support
58.59
- R3 67.47
- R2 63.99
- R1 62.07
- S1 56.67
- S2 53.19
- S3 51.27
Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-10 | Quarterly Results | |
| 2025-11-12 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-16 | Audited Results | |
| 2025-02-07 | Quarterly Results |
Aspira Pathlab & Diagnostics F&O
About Aspira Pathlab & Diagnostics
- NSE Symbol
- ASPIRA
- BSE Symbol
- 540788
- Managing Director & CEO
- Dr. Pankaj J Shah
- ISIN
- INE500C01017
Similar Stocks to Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics FAQs
Aspira Pathlab & Diagnostics share price is ₹60 As on 14 March, 2026 | 14:18
The Market Cap of Aspira Pathlab & Diagnostics is ₹61.9 Cr As on 14 March, 2026 | 14:18
The P/E ratio of Aspira Pathlab & Diagnostics is 42.2 As on 14 March, 2026 | 14:18
The PB ratio of Aspira Pathlab & Diagnostics is 4.8 As on 14 March, 2026 | 14:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.